The impact of very early antiretroviral therapy on immune responses and HIV reservoirs: implications for HIV cure strategies

 30 November 2022

Prof Thumbi Ndung’u is the Director of Basic and Translational Science at AHRI in Durban. He is a Professor of Infectious Diseases at University College London and holds the SARChi in Systems Biology of HIV / AIDS and the victor Daitz Chair in HIV/TB Research at the HIV Pathogenesis Programme, Nelson R Mandela School of Medicine, University of KwaZulu-Natal. He is the Programme Director of the sub-

Saharan African Network for TB /HIV Research Excellence (SANTHE). a research and capacity-building initiative. He is an Associate Member of the Ragon Institute of MGH, MIT and Harvard University. He graduated with a Bachelor of Veterinary Medicine degree from the University of Nairobi, Kenya and a PhD in Biological Sciences in Public Health from Harvard University. He did postdoctoral research in Virology at Harvard Medical School. He is a recipient of the SAMRC Gold award for seminal scientific contributions that have impacted the health of people. He is a member of the Academy of Science of South Africa and a fellow of the African Academy of Sciences. He has co-authored more than 250 peer-reviewed publications. His research focuses on understanding how the immune system may be harnessed for HIV prophylactic or therapeutic strategies.

 Recording of seminar